Search For "bharat biotech vaccine"
Bharat Biotech begins clinical trials of TB vaccine 'MTBVAC' on adults in
Updated : 2 years, 2 months ago IST
As per Bharat Biotech, MTBVAC is the first vaccine against Tuberculosis derived from a human source by the Spanish biopharmaceutical company, Biofabri.
Read More
COVID-19: India's first intranasal vaccine by Bharat Biotech gets DCGI app
Updated : 3 years, 9 months ago IST
New Delhi [India], September 6 (ANI): The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India (DCGI) for the Intranasal Covid-19 vaccine.
Read More
Bharat Biotech completes clinical development for phase III trials, booste
Updated : 3 years, 9 months ago IST
Hyderabad (Telangana) [India], August 15 (ANI): Bharat Biotech International on Monday said that BBV154 (intranasal vaccine) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.
Read More
No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO susp
Updated : 4 years, 2 months ago IST
Hyderabad (Telangana)[India], April 3 (ANI): Hyderabad-based Bharat Biotech on Sunday issued a clarification that there is "no impact on efficacy and safety of the COVID-19 vaccine COVAXIN" after the World Health Organisation suspended it from its Covax facility.
Read More
DCGI's expert panel to review Phase III data of Covaxin today
Updated : 4 years, 11 months ago IST
New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat Biotech's Covaxin on Tuesday.
Read More
Chidambaram seeks CAG-driven audit of vaccine production, says mystery of
Updated : 5 years ago IST
New Delhi [India], May 29 (ANI): Congress leader P Chidambaram said on Saturday that the mystery of the "missing vaccines" is deepening every day and a CAG driven full-scope audit of capacity, production, despatch, supply and customers' lists of two domestic manufacturers of COVID-19 vaccin
Read More
Centre, Bharat Biotech willing to invite other companies to scale up Covax
Updated : 5 years ago IST
New Delhi [India], May 13 (ANI): Amid the reports of vaccine shortage from various state, Central government and Hyderabad based Bharat Biotech is willing to invite other companies who want to produce COVAXIN to increase the production, said NITI Aayog member, Dr VK Paul, on Thursday.
Read More
Subject Expert Committee gives nod to Covaxin for Phase 2, 3 trials on chi
Updated : 5 years ago IST
New Delhi [India], May 12 (ANI): The Subject Expert Committee (SEC) has given a nod to Bharat Biotech's Covaxin for Phase 2 and 3 human clinical trials on children aged between two to eight years old, sources confirmed on Wednesday.
Read More
COVAXIN neutralises multiple variants of SARS-COV-2, double mutant strain:
Updated : 5 years, 1 month ago IST
New Delhi [India], April 21 (ANI): Indigenously-developed Covid-19 vaccine Covaxin, made by Bharat Biotech, neutralises multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well, the Indian Council of Medical Research (ICMR) said on Wednesday.
Read More
Covishield, Covaxin manufacturers get financial assistance from govt to ra
Updated : 5 years, 1 month ago IST
New Delhi [India], April 20 (ANI): Finance Minister Nirmala Sitharaman has approved a total of Rs 4,567.50 crore as advance payment to Serum Institute of India (SII) and Bharat Biotech to ramp up vaccine production against coronavirus, sources told ANI.
Read More
Mauritius receives consignment of Made in India COVID-19 vaccines
Updated : 5 years, 2 months ago IST
Port Louis [Mauritius], March 19 (ANI): In a unified attempt to free the world of coronavirus, India on Friday handed over to Mauritius a commercial supply of 200,000 doses of Covaxin vaccines under the 'Vaccine Maitri' initiative.
Read More
Bharat Biotech confirms deal with Brazil to supply 20 million doses of Cov
Updated : 5 years, 3 months ago IST
New Delhi [India], February 26 (ANI): Bharat Biotech International Limited on Friday confirmed that the company has signed an agreement with Brazil for the supply of 20 million doses of Covaxin vaccine.
Read More